Background {#Sec1}
==========

In the last few years, hospital length of stay (LOS) after primary total knee arthroplasty (TKA) has decreased following the implementation of enhanced recovery after surgery (ERAS) program \[[@CR1], [@CR2]\]. This ERAS program is a series of perioperative multimodal strategies to enhance recovery and reduce morbidity \[[@CR1]\]. Enhanced-recovery TKA has been shown to be safe and feasible, with similar or better outcomes for the patients \[[@CR2], [@CR3]\].

In literature, although the postoperative LOS (PLOS) of TKA has decreased substantially, there are still some risk factors that influence PLOS including older age \[[@CR4]--[@CR7]\], female \[[@CR5]--[@CR7]\], increased body mass index (BMI) \[[@CR4], [@CR8]\], American Society of Anesthesiologists (ASA) score 3/4 \[[@CR5], [@CR6]\], surgery on Thursday or Friday \[[@CR6], [@CR9]\], not ambulating on day of surgery \[[@CR10]--[@CR12]\], and postoperative complications \[[@CR7], [@CR11]\]. However, some of those studies have investigated prolonged PLOS in the absence of an ERAS program \[[@CR5], [@CR7]\], focused only on preoperative patient characteristics \[[@CR4]\], not mentioning the definition of prolonged PLOS \[[@CR4], [@CR9], [@CR11]\]. Furthermore, factors such as pain level, preoperative knee function, perioperative laboratory examination, surgical factors, and postoperative complications were often rarely mentioned.

The ERAS program of TKA in our hospital was also introduced with the aim to reduce PLOS to a mean of 3 days with equal or higher quality of care. To find starting points for further reduction of the PLOS in the future, we studied a consecutive series of 241 patients admitted for primary TKA to identify all risk factors for prolonged PLOS in combination with the ERAS program. Specifically, the relationships between PLOS, patient demographics, comorbidities, surgical factors, and postoperative complications were assessed. It was hypothesized that several preoperative and postoperative variables are factors that influence PLOS after TKA, such as comorbidities, preoperative knee function, pain level, and postoperative complications.

Methods {#Sec2}
=======

We retrospectively reviewed a consecutive series of 241 patients who underwent unilateral elective primary TKA from July 2015 to March 2017 in our hospital. Institutional review board approval was obtained. The primary outcome of the study was PLOS, defined as the number of nights from surgery to discharge because all patients were admitted to the hospital several days before the surgery. Since the standard target for discharge in our practice was postoperative day 3, prolonged hospitalization was defined as PLOS \> 3. There were 123 (51.0%) patients who had a PLOS ≤ 3 days and 118 (49.0%) a PLOS \> 3 days. All surgeries were performed in an ERAS program and by one experienced surgeon performing \> 100 TKAs per year.

ERAS program {#Sec3}
------------

All patients had access to the full ERAS program, which included preoperative, perioperative, and postoperative protocols for the delivery of care (Table [1](#Tab1){ref-type="table"}).Table 1Strategies of the ERAS program for TKAPatients' education Inform detailed treatment process and rehabilitation plan Continue knee joint functional exercise every hour during the dayNutritional support and diet managements Take high-protein dietary for at least 2 days before surgery Individualized diet management on day of surgery: individually preoperative fasting and water-deprivation according to the operation time, oral carbohydrate solution 2 h before surgery, and early postoperative feeding on day of surgery.General anesthesiaRestrictive fluid management Intravenous crystalloid fluid volume controls in about 1500 ml on day of surgeryMinimally invasive operation A middle skin incision, a standard medial parapatellar approach, and a measured resection technique.Blood managements Erythropoietin and chalybeate were used in patients with anemia (hemoglobin: male \< 130 g/L; female \< 120 g/L) Controlled hypotension (mean arterial pressure: 70 to 80 mmHg) during operation Tranexamic acid (TXA) utilization: a dose of 20 mg/kg intravenous TXA (IV-TXA) was given before incision, another two doses of 10 mg/kg or 1 g IV-TXA 3 and 6 h later.Pain managements Preventive analgesia with celecoxib orally preoperatively Local infiltration of 80 mL 2.5% ropivacaine before incision closure A standard regimen of oral nonsteroidal anti-inflammatory drugs (NSAIDs) after surgery, oral oxycodone as needed.No allogenic blood transfusionNo tourniquet during operationNo urine catheter before surgery, catheter would be used for postoperative uroschesis.No drainage tube or early removal of drainage tube after surgeryAntithrombotic prophylaxis Low-molecular-weight heparin daily, starting 6 h postoperatively and given until discharge, then oral rivaroxaban 5 or 10 mg daily for 10 days.Prevention of postoperative nausea and vomiting Oral mosapride 5 mg 2 h before surgery and postoperatively three times a day Dexamethasone 10 mg intravenous injection during operation and a repeat dose was given 4 to 6 h after surgeryStart rehabilitation and mobilization on day of surgery Perform ankle flexion and extension exercises in bed immediately after surgery, then progressive ambulation exercises with full weight bearing on the first or second postoperative day with the assistance of a walker or crutches.Discharge criteria Be self-dependent, able to walk with crutches or better, able to achieve 100° active knee flexion or better and − 5° to 0° extension.

Study outcomes {#Sec4}
--------------

The potential variables associated with PLOS including preoperative patient characteristics, perioperative surgical factors, and postoperative complications were all collected during the inpatient hospital stay. Patient demographics of age, gender, BMI, diagnosis, comorbidities, ASA score, and preoperative knee function including flexion range of motion (ROM), varus or valgus deformity, and hospital for special surgery (HSS) knee score were recorded. Visual analogue scale (VAS) pain score, the serum level of hemoglobin (Hb), albumin, C-reactive protein (CRP), and interleukin-6 (IL-6) were recorded preoperatively and on postoperative days 1 and 3 (POD1, POD3). Perioperative surgical factors included operative time, surgery start time, intravenous fluid volume on day of surgery, total blood loss calculated by gross equation \[[@CR13]\], utilization of catheter and drainage tube, and time to ambulate and achieve 90° active knee flexion after surgery. Postoperative complications including wound complications and other minor complications and preoperative LOS were also compared in two groups.

Statistical analysis {#Sec5}
--------------------

Results were summarized using the mean and standard deviation for continuous variables, and counts and percentages for categorical variables. Continuous variables were tested for normality using the Kolmogorov-Smirnov test. Variables determined to be normally distributed were compared using Student's *t* test, while variables non-normally distributed were compared using the Kruskal-Wallis non-parametric test. The relationship between each categorical variable and PLOS \> 3 days was assessed using the chi-square test. If any expected or observed value was less than or equal to 5, Fisher's exact test was used. All statistical tests were two-sided, and a *P* value of ≤ 0.05 was considered statistically significant. Following univariable analyses, significant factors were subjected to a stepwise multivariable logistic regression analysis to determine variables associated with prolonged PLOS using a *P* value ≤ 0.05 to remain in the model. Odds ratios (OR), corresponding 95% confidence intervals (CI), and *P* values were computed. IBM SPSS version 19.0 was used for all analyses.

Results {#Sec6}
=======

Two-hundred forty-one consecutive primary TKA patients were included in the study (18.3% male, 81.7% female). The mean age was 65.9 years (range 38--89 years) while the mean BMI was 25.5 kg/m^2^ (range 14.5--35.9 kg/m^2^). Preoperative diagnosis was osteoarthritis (94.2%) or rheumatoid arthritis of the knee (5.8%). The patient characteristics and preoperative, perioperative, and postoperative variables of the study cohort are outlined in Table [2](#Tab2){ref-type="table"}.Table 2The patient characteristics and preoperative, perioperative and postoperative variables by PLOS of patients underwent TKA (*N* = 241)VariablePLOS ≤ 3PLOS \> 3*P* value*N*123118Age (years)65.5 ± 8.366.4 ± 8.50.374Gender0.856 Male23 (18.7%)21 (17.8%) Female100 (81.3%)97 (82.2%)BMI (kg/m^2^)25.5 ± 3.525.5 ± 3.70.866Diagnosis0.027 Osteoarthritis120 (97.6%)107 (90.7%) Rheumatoid arthritis3 (2.4%)11 (9.3%)Comorbidities Hypertension79 (64.2%)74 (62.7%)0.807 Diabetes17 (13.8%)20 (16.9%)0.501 Heart disease12 (9.8%)11 (9.3%)0.909 Pulmonary infection7 (5.7%)22 (18.6%)0.002ASA score0.003 ≤ 2112 (91.1%)91 (77.1%) 3/411 (8.9%)27 (22.9%)Preoperative knee function Flexion ROM (degrees)105.2 ± 12.298.6 ± 17.90.001 Varus deformity72 (58.5%)66 (55.9%)0.683 Valgus deformity5 (4.1%)19 (16.1%)0.002 HSS score50.9 ± 9.648.0 ± 8.20.014VAS pain score Preoperatively4.8 ± 0.85.1 ± 0.90.007 POD11.8 ± 0.71.9 ± 0.80.307 POD31.1 ± 0.41.3 ± 0.6\< 0.001Hb (g/L) Preoperatively129.4 ± 14.0130.6 ± 13.50.478 POD1117.4 ± 12.9117.1 ± 12.40.879 POD3109.4 ± 11.2108.2 ± 11.90.408Albumin (g/L) Preoperatively43.0 ± 3.142.4 ± 3.40.186 POD138.9 ± 2.938.6 ± 3.10.378 POD336.4 ± 2.636.2 ± 3.40.674CRP (mg/L) Preoperatively3.4 ± 2.74.4 ± 5.00.070 POD123.6 ± 17.229.8 ± 20.60.011 POD341.8 ± 30.663.1 ± 44.7\< 0.001IL-6 (ng/L) Preoperatively5.2 ± 5.44.5 ± 3.00.219 POD133.1 ± 29.053.6 ± 42.1\< 0.001 POD325.9 ± 22.833.5 ± 27.90.021Operative time (min)80.1 ± 17.280.2 ± 15.20.982Surgical start time0.001 Before 2 PM105 (85.4%)80 (67.8%) After 2 PM18 (14.6%)38 (32.2%)Intravenous fluid volume (ml)1464.5 ± 433.71533.1 ± 495.60.253Total blood loss (ml)595.0 ± 341.0685.8 ± 373.60.050Utilization of catheter13 (10.6%)28 (23.7%)0.007Utilization of drainage tube48 (39.0%)63 (53.4%)0.025Time to ambulate (day after surgery)0.9 ± 0.41.2 ± 0.6\< 0.001Time to achieve 90° active knee flexion (day after surgery)1.5 ± 0.61.9 ± 0.8\< 0.001Wound complications3 (2.4%)27 (22.9%)\< 0.001Other minor complications8 (6.5%)39 (33.1%)\< 0.001Preoperative LOS (day)4.8 ± 1.45.6 ± 2.60.006*PLOS* postoperative length of stay, *BMI* body mass index, *ASA score* American Society of Anesthesiologists score, *ROM* range of motion, *HSS score* hospital for special surgery knee score, *VAS* visual analogue scale, *POD1* postoperative day 1, *POD3* postoperative day 3, *Hb* hemoglobin, *CRP* C-reactive protein, *IL-6* interleukin-6; total blood loss, calculated by gross equation, *LOS* length of stay

The mean PLOS was 3.8 days (range 2--9 days) with a median of 3.0 days. There were 123 (51.0%) patients who had a PLOS ≤ 3 days and 118 (49.0%) a PLOS \> 3 days. Table [2](#Tab2){ref-type="table"} outlines the univariable relationship of each variable with PLOS. Univariable analyses revealed a significant independent association between PLOS and diagnosis, preoperative pulmonary infection, ASA score, preoperative flexion ROM, valgus deformity, HSS score of the knee, VAS pain score preoperatively and on POD3, serum level of CRP and IL-6 on POD1 and 3, surgical start time, total blood loss, utilization of catheter and drainage tube, time to ambulate and achieve 90° active knee flexion after surgery, and wound complications and other minor complications. However, after multivariable adjustment, only preoperative valgus deformity of the knee (OR 4.95, 95%CI 1.56--15.77, *P* = 0.007), increased serum level of IL-6 on POD1 (OR 1.01, 95%CI 1.00--1.03, *P* = 0.039), increased VAS pain score on POD3 (OR 2.56, 95%CI 1.28--5.13, *P* = 0.008), increased serum level of CRP on POD3 (OR 1.01, 95%CI 1.00--1.03, *P* = 0.019), increased day to achieve 90° active knee flexion after surgery (OR 2.19, 95%CI 1.27--3.79, *P* = 0.005), wound complications (OR 8.58, 95%CI 2.10--35.03, *P* = 0.003), and other minor complications (OR 6.04, 95%CI 2.40--15.19, *P* \< 0.001) remained significantly associated with prolonged PLOS in the final multivariable logistic regression model (Table [3](#Tab3){ref-type="table"}).Table 3Multivariable logistic regression model for factors of PLOS \> 3 daysFactorOdds ratio95%CI*P* valuePreoperative valgus deformity of the knee4.951.56--15.770.007Increased serum level of IL-6 on POD11.011.00--1.030.039Increased VAS pain score on POD32.561.28--5.130.008Increased serum level of CRP on POD31.011.00--1.030.019Increased day to achieve 90° active knee flexion after Surgery2.191.27--3.790.005Wound complications8.582.10--35.030.003Other minor complications6.042.40--15.19\< 0.001*PLOS* postoperative length of stay, *IL-6* interleukin-6, *POD1* postoperative day 1, *VAS* visual analogue scale, *POD3* postoperative day 3, *CRP* C-reactive protein

Thirty patients (12.4%) developed postoperative wound complications after surgery mainly including swelling (53.3%) and exudation (43.3%). Forty-seven patients (19.5%) developed other minor complications, which were predominately narcotic-related adverse drug events such as postoperative nausea and vomiting (PONV, 42.6%), fever (23.4%), hypotension (12.8%), and confusion (8.5%). Eleven patients (4.6%) developed both wound and other minor complications. Preoperative pulmonary infection (OR 2.75, 95%CI 1.20--6.28, *P* = 0.016), ASA score 3/4 (OR 2.14, 95%CI 1.01--4.52, *P* = 0.046), and utilization of catheter after surgery (OR 2.53, 95%CI 1.23--5.19, *P* = 0.012) were significantly associated with postoperative complications (Table [4](#Tab4){ref-type="table"}).Table 4Multivariable logistic regression model for risk factors of postoperative complicationsFactorOdds ratio95%CI*P* valuePreoperative pulmonary infection2.751.20--6.280.016ASA score 3/42.141.01--4.520.046Utilization of catheter after surgery2.531.23--5.190.012*ASA score* American Society of Anesthesiologists score

Discussion {#Sec7}
==========

The most important finding of the present study was that preoperative valgus deformity of the knee, increased serum level of IL-6 on POD1, increased VAS pain score and serum level of CRP on POD3, increased day to achieve 90° active knee flexion after surgery, and postoperative wound complications and other minor complications were associated with prolonged PLOS of TKA. Meanwhile, preoperative pulmonary infection, ASA score 3/4, and utilization of catheter after surgery were statistically significant contributors in postoperative complications. This is a complete and systematic study in which preoperative, perioperative, and postoperative variables were all recorded and analyzed in patients who underwent TKA with the ERAS program. Moreover, factors such as preoperative valgus deformity of the knee and perioperative laboratory examination and pain level were investigated for the first time.

In the present study, the ERAS program focuses on the improvement of surgical techniques and optimization of perioperative management, which mainly contains preoperative patients' education, nutritional support, minimally invasive operation, perioperative blood management, multimodal pain management, prevention of infection, venous thromboembolism and PONV, optimizing the use of drainage tube, catheter and tourniquet, and functional exercise. After implementation of the ERAS program, the patients who underwent TKA in our hospital could be discharged home on POD3. This study design may explain some of the discrepancies between previous studies without ERAS program and ours. In particular, we did not find an association between PLOS and age \[[@CR5], [@CR7]\], gender \[[@CR5], [@CR7]\], or BMI \[[@CR4]\]; undeniably, this difference may be related to the characteristics of population.

Several studies have explored the association between comorbidities and PLOS \[[@CR5]--[@CR7], [@CR14]\]. Winemaker et al. \[[@CR14]\] reported that pre-existing cardiac comorbidities and diabetes treated orally were strong predictors of prolonged PLOS. However, the existence of heart disease or diabetes preoperatively differs from the control level of the diseases, which explain the reverse finding in the current study to some extent. ASA score, which is indicative of comorbidity, has been demonstrated to be predictive of prolonged hospital stay \[[@CR5], [@CR6]\]. Some preoperative comorbidities have been established to be predictive complications which are in turn linked to prolonged PLOS \[[@CR5]\]. This is in accordance with our finding that patients with an ASA score 3/4 and preoperative pulmonary infection were 2.14 and 2.75 times more likely to have a postoperative stay \> 3 days.

In the present study, preoperative knee function was associated with prolonged PLOS. This is in accordance with other studies \[[@CR3], [@CR15]\] on PLOS after TKA, with ERAS program as well as without ERAS program. Moreover, in addition to find that preoperative valgus deformity of the knee was an independent risk factor of prolonged PLOS, we observed that as the day to achieve 90° active knee flexion after surgery increases, the patients were more likely to have a prolonged PLOS. Previous studies rarely show these two variables as risk factors for PLOS, but instead they identified preoperative ROM of the knee or the use of walking aids \[[@CR3], [@CR15]\]. Mobilization as early as 4 to 6 h after surgery can help achieve functional recovery, reduce hospital stays, and improve functional outcomes \[[@CR16]\].

Halawi et al. \[[@CR17]\] retrospectively reviewed 112 consecutive patients who underwent total hip arthroplasty and found a significant association between PLOS and preoperative pain level. In this study, we analyzed the relationship between VAS pain score preoperatively and on POD1, POD3, and PLOS of TKA. Interestingly, we found that increased VAS pain score on POD3 was significantly associated with prolonged PLOS while preoperative VAS pain score was not. Postoperative pain remains an important barrier to early discharge of TKAs, and it has a major influence on the ability of the patient to resume normal activities at home \[[@CR18]\]. Effective analgesia in the immediate postoperative phase is important to allow the patient to exercise and regain mobility, facilitating recovery while decreasing the PLOS.

Reducing surgical trauma is a target of TKA with the ERAS program; this could be evaluated by postoperative inflammation makers such as CRP and IL-6 level in serum. As Windisch et al. \[[@CR19]\] reported, CRP increased within a few hours after TKA, with a maximum value between postoperative day 2 and POD3, then falling again to the normal level. This is consistent with the finding by Xie et al. \[[@CR20]\] in which IL-6 level reached maximum on POD1. Therefore, we investigated the relationship between serum level of CRP and IL-6 on POD1, POD3, and PLOS of TKA. After a stepwise multivariable logistic regression analysis, we found that increased serum level of CRP on POD3 and increased serum level of IL-6 on POD1 were risk factors of prolonged PLOS. This is essential to monitor CRP and IL-6 in serum after TKA, although they were not strong predictors.

Postoperative complication as a risk factor for prolonged PLOS had been found in previous studies \[[@CR7], [@CR11], [@CR21], [@CR22]\]. However, in these studies, few had mentioned specific complications \[[@CR7]\] or rarely investigated entire postoperative adverse events \[[@CR11]\]. In our study, we found that patients who sustained wound complications or other minor complications were 8.58 and 6.04 times more likely to have a postoperative stay \> 3 days compared to patients with no complication. Swelling and exudation were mainly wound complications, while other minor complications mainly included PONV, fever, hypotension, and confusion. These finding were consistent with findings in the literature \[[@CR11], [@CR22]\]. Furthermore, our study also found that preoperative pulmonary infection, ASA score 3/4, and utilization of catheter after surgery were significantly associated with postoperative complications in the multivariable logistic regression model. Therefore, every effort should be done to make further optimization on the patient's medical comorbidities and reduce the utilization of catheter after surgery in order to have more favorable outcomes following TKA and decrease postoperative complications as well as PLOS.

There are several limitations to our study worth mentioning. Firstly, it was a retrospective chart review from a single tertiary-care teaching institution, while a prospective study might have provided us with additional information to predict the PLOS better. Moreover, the sample was relatively small in that a valid conclusion regarding age, gender, and BMI could not be made. Secondly, the need for blood transfusion may influence the PLOS of TKA \[[@CR12], [@CR23]\]. In the present study, this was not taken into account, since there was no patient who needed blood transfusion. Thirdly, we did not investigate the relationship between discharge destination and PLOS, because of that, every patient could be discharged home if they reached the discharge criteria in our hospital. Lastly, 30- and 90-day readmission was not assessed in the present study. Ricciardi et al. \[[@CR24]\] demonstrated that short PLOS was a risk factor for 30- and 90-day readmission after TKA, while Sutton et al. \[[@CR25]\] thought that early discharge was not an independent risk factor for 30-day major complications or readmissions following TKA. Therefore, further research should investigate whether early discharge influences the readmission rate of TKA with the ERAS program.

Conclusions {#Sec8}
===========

In conclusion, preoperative valgus deformity of the knee, increased serum level of IL-6 on POD1, increased VAS pain score, and serum level of CRP on POD3, increased day to achieve 90° active knee flexion after surgery, and postoperative wound complications and other minor complications were associated with prolonged PLOS in the ERAS program for primary TKA. Preoperative pulmonary infection, ASA score 3/4, and utilization of catheter after surgery were statistically significant contributors in postoperative complications. It is important to recognize all the factors that associated with prolonged PLOS to try to maximize the use of medical resources and ultimately optimize the care of our patients.
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